HappeningToo topic
Dupilumab reports
Browse community reports connected to Dupilumab. These reports can show that other people are describing similar experiences, but they do not prove that Dupilumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
32 problems
Alopecia while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and alopecia appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and back pain appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and cough appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dermatitis while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and dermatitis appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and diarrhea appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and dizziness appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Eye while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and dry eye appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and dry skin appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Eye Irritation while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and eye irritation appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Eye Pain while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and eye pain appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and fatigue appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and headache appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and hives appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and insomnia appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and itching appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and malaise appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and myalgia appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and nausea appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and oropharyngeal pain appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and pain appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash Erythematous while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and rash erythematous appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash Macular while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and rash macular appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and rash appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and shortness of breath appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and skin redness appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleep Disorder while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and sleep disorder appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and swelling appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and tingling or pins and needles appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and vision blurred appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and vomiting appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Watery eyes while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and watery eyes appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Dupilumab
FDA FAERS contains adverse-event reports in which Dupilumab and weight increased appear together. This does not establish that Dupilumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →